News

In Case You Missed It: Healthcare Stocks in 2013

It's been a wild ride for the Healthcare sector in 2013. It's been a wild ride for most equities, really, but Healthcare has been among those experiencing the biggest gains. While the S&P 500 boasted a 28.55 percent gain through Christmas, the SPDR Health Care Select Sector Fund ($XLV) climbed 37.96 percent over that same period. And those gains were bigger for biotech, with the SPDR S&P Biotech ETF ($XBI) gaining 48.12 percent and the iShares Nasdaq Biotechnology Index Fund ($IBB) up 64.33 percent.

And all this coming during the same year that the key portion of the biggest piece of healthcare legislation in a decade got to a creaky false start followed by a more robust restart. So, in case you missed it, here are some of Equities.com's best stories from 2013:

Obamacare

The entire healthcare industry is in a state of flux, and much of its future appears to be riding on the success or failure of President Barrack Obama's key piece of legislation: the Affordable Care Act. And for those of you scratching your heads, yes, that's Obamacare. The rollout of the exchanges was fumbled (the President's words, not mine), and the administration has backtracked on some of its requirements already, but the law really hinges on how many people are enrolled by the end of the open enrollment period in March. The law was explored as part of our six-part series What is Obamacare?

DISCLOSURE:
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer